Our Take
PwC is diagnosing the problem correctly—AI documentation tools are helping providers extract higher payments—but the prescribed fixes (payment integrity, utilization management) are not new and assume payers can move faster than providers innovate.
Why it matters
Employers and health plan members face the steepest premium increases since 2010. The watershed moment arrives now because providers are embedding AI into revenue capture workflows faster than payers can audit claims.
Do this week
Benefits manager: audit your claims data for coding intensity drift and AI-assisted documentation patterns before Q4 budget planning so you can reset reimbursement rates with providers under contract renewal.
Medical cost trend hits 17-year peak
Commercial health plans are projecting a 9% medical cost increase for 2027, the highest rate in 17 years (per PwC analysis). The surge reflects five converging pressures: AI-enabled documentation and coding tools capturing incremental provider revenue; inflation and consolidation driving reimbursement rates higher; rising pharmacy costs, particularly GLP-1 medications; increased behavioral health utilization; and the No Surprises Act arbitration process creating new out-of-network payment obligations.
PwC frames this as a "watershed moment" for the healthcare system and recommends five cost-of-care countermeasures: payment integrity (pre-claim audits and severity tracking); targeted utilization management (retiring low-yield prior authorizations); pharmacy governance (GLP-1 access policies, biosimilar acceleration); network and reimbursement strategy (price transparency, value-based contract resets); and disciplined care management with measurable avoided-utilization targets.
AI-driven provider revenue capture is outpacing payer controls
The critical detail buried in the PwC recommendation is the acknowledgment that "AI-enabled documentation and coding tools" are producing measurable increases in paid amounts per claim and coding intensity variation. Payers see this already. The challenge is that providers are adopting these tools at scale (company-reported adoption is rising but not quantified in the PwC report) while health plans are still designing audit workflows and claims-editing infrastructure that rely on traditional variance thresholds.
PwC does not claim that its recommended strategies will close this gap. The report instead cites employer affordability limits: "employers will likely not be able to sustain the same benefits" in coming years. This is not a payer victory. It is a forecast of benefit erosion and cost-shifting to members and employees.
What health plan finance teams should do now
Start with payment integrity, but recognize the scope creep. Claims edits and pre-payment audits work when the variation is random coding error. They become asymmetric when provider AI tools are systematically classifying severity upward within policy. Payers should map which providers have adopted AI documentation platforms (most major health systems have, though provider-level data is opaque) and benchmark their coding intensity against year-over-year baselines in 2024–2025.
Second, lock contract terms now. Value-based payment models and site-of-care directives require 12–18 months to operationalize. Waiting until 2026 to negotiate specialty pharmacy and behavioral health carve-outs will mean accepting 2027 rates that already reflect 2026 utilization spikes. GLP-1 medications alone are driving category-level cost jumps; disciplined access policies by indication need to be in place before 2027 enrollments.
Third, assume internal staffing limits. The five PwC recommendations all assume payers have analysts, clinical reviewers, and contract specialists to implement them. Most mid-sized plans do not. Outsourcing vendor selection and outcome-based contracting (tying payment to measurable savings, not activity) will matter more than process redesign.